NIH begins testing of universal mRNA flu “vaccines” for annual gene-editing ritual

Now that the Wuhan coronavirus (Covid-19) “pandemic” is over, the pharmaceutical industry and its partners at the National Institutes of Health (NIH) are busily working on a universal mRNA influenza “vaccine” that they aim to push the public into taking annually once it is completed.